Increased IL-2 production in CF patients (both with and without MABSC history), but not in non-CF controls, suggests that effector T cells are present in CF patients to some extent when their PBMC are challenged with MABSC and (in the case of patients without NTM history) possibly indicating previous exposure to NTM. Here, IL2 is linked to cystic fibrosis.